Loading...

Incentives for medical devices using robotics, AI, 3D Printing in Korea

Image

18-Apr-17 In Korea, an evaluation and compensation system will be applied to medical devices using innovative technologies such as robotics, artificial intelligence and 3D printing. “We will continue to improve systems and give supports so that the healthcare industry will develop into a future growth engine" said Kim Gang-rip, director of the Ministry of Health and Welfare. [image: Business Korea]

Read More

Samsung Medison launches compact ultrasound system

Image

18-Apr-17 Samsung Medison is going to pursue a quantitative growth by focusing on the low-end market using “HS40.” Samsung Medison CEO Jun Dong-soo said “The HS40, has kept multiple functions and improved usability for effective diagnosis." [image: Business Korea]

Read More

Medtronic’s Ishrak sees Chinese health reform as boon to the medical device business

Image

14-Apr-17 Healthcare reform in China could be a major boon to Medtronic, says CEO Omar Ishrak who told the China Daily "in 10 years, probably, the Chinese market would have outpaced the US market." Ishrak added, Medtronic would open a heart-valve manufacturing site in Shanghai, saying "the facility would help relieve the shortage of such valves in China and globally." [image: Medtronic]

Read More

Tijuana, Mexico finds its place as a leader in medical device manufacturing

Image

11-Apr-17 The North American Free Trade Agreement has led to the transformation of Tijuana to become one of the world capitals in the manufacture of medical devices. The manufacturing units located in Tijuana make millions of medical devices from intravenous bags to artificial respirators. Many American med-device companies have manufacturing facilities in TiJuana, including Medtronic, Carefusion, and DJO Global. [image: John Francis Peters / New York Times]

Read More

Many American healthtech companies would have more success in emerging markets

Image

06-Apr-17 Global healthcare spending is roughly USD7 tn, according to the US Department of Commerce and many companies would have more success pursuing product approval in emerging markets as the technologies may be more helpful for those patient populations and the regulatory burdens more manageable, suggested Matthew Hein, representative for the US DoC at the MedTech Intelligence Global Regulatory conference. [image: MedTech Intelligence]

Read More
Share